| Literature DB >> 28630052 |
Guillermo Rodríguez-Hernández1,2, Julia Hauer3, Alberto Martín-Lorenzo1,2, Daniel Schäfer3, Christoph Bartenhagen4, Idoia García-Ramírez1,2, Franziska Auer3, Inés González-Herrero1,2, Lucia Ruiz-Roca1,2, Michael Gombert3, Vera Okpanyi3, Ute Fischer3, Cai Chen3, Martin Dugas4, Sanil Bhatia3, René Martin Linka3, Marta Garcia-Suquia5, María Victoria Rascón-Trincado5, Angel Garcia-Sanchez5,6, Oscar Blanco2,7, Maria Begoña García-Cenador2,8, Francisco Javier García-Criado2,8, César Cobaleda9, Diego Alonso-López10, Javier De Las Rivas2,10,11, Markus Müschen12, Carolina Vicente-Dueñas2, Isidro Sánchez-García1,2, Arndt Borkhardt13.
Abstract
ETV6-RUNX1 is associated with the most common subtype of childhood leukemia. As few ETV6-RUNX1 carriers develop precursor B-cell acute lymphocytic leukemia (pB-ALL), the underlying genetic basis for development of full-blown leukemia remains to be identified, but the appearance of leukemia cases in time-space clusters keeps infection as a potential causal factor. Here, we present in vivo genetic evidence mechanistically connecting preleukemic ETV6-RUNX1 expression in hematopoetic stem cells/precursor cells (HSC/PC) and postnatal infections for human-like pB-ALL. In our model, ETV6-RUNX1 conferred a low risk of developing pB-ALL after exposure to common pathogens, corroborating the low incidence observed in humans. Murine preleukemic ETV6-RUNX1 pro/preB cells showed high Rag1/2 expression, known for human ETV6-RUNX1 pB-ALL. Murine and human ETV6-RUNX1 pB-ALL revealed recurrent genomic alterations, with a relevant proportion affecting genes of the lysine demethylase (KDM) family. KDM5C loss of function resulted in increased levels of H3K4me3, which coprecipitated with RAG2 in a human cell line model, laying the molecular basis for recombination activity. We conclude that alterations of KDM family members represent a disease-driving mechanism and an explanation for RAG off-target cleavage observed in humans. Our results explain the genetic basis for clonal evolution of an ETV6-RUNX1 preleukemic clone to pB-ALL after infection exposure and offer the possibility of novel therapeutic approaches. Cancer Res; 77(16); 4365-77. ©2017 AACR. ©2017 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28630052 DOI: 10.1158/0008-5472.CAN-17-0701
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701